Clinical Trial Update: Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing intralesional acyclovir versus Candida antigen for plantar warts; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plantar Wart

Drugs mentioned

• ACYCLOVIR (Acyclovir)
• Candida antigen (candida antigen)

Snippet

Sponsor: Sohag University | Conditions: Acyclovir and Candida Antigen in Treatment of Plantar Wart | Phase 4 | Status: UNKNOWN